Triamcinolone acetonide: Preparation for intravitreal injection

International Journal of Ophthalmology

Volumn 5, Issue 5, 2005, Pages 881-883

  Kreissig, Ingrid ^a   Jonas, Jost B ^a   Vossmerbaeumer, Urs ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Endophthalmitis; Filtration; Intravitreal injection; Ocular hypertension; Preparation; Triamcinolone acetonide; Vehicle, dosage

Indexed keywords

BENZYL ALCOHOL; DRUG VEHICLE; TRIAMCINOLONE ACETONIDE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; ENDOPHTHALMITIS; FILTRATION; FOLLOW UP; HUMAN; INJECTION; INTRAOCULAR HYPERTENSION; MICROCRYSTALLINE SUSPENSION; NONHUMAN;

EID: 28644435607     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hefferman JT, Futterman S, Kalina RE. Dexamethasone inhibition of experimental endothelial cell proliferation in retinal venules. Invest Ophthalmol Vis Sci ,1978; 17: 565-568
2. Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol ,1985;103;708-11
3. Graham RO, Peyman GA. Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis. Arch Ophthalmol ,1974;92: 149-154
4. Machemer R, Sugita G, Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc ,1979;77:171-180
5. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of tramcinolone acetonide. Am J Ophthalmol ,1980; 90: 810-816
6. Peyman GA, Cheema R, Conway MD, Fang T. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plans vitrectomy. Retina ,2000;20:554-555
7. Scholes GN, O'Brien WJ, Abrams GW, Kubicek MF. Clearance of triamcinolone from vitreous. Arch Ophthalmol ,1985;103:1567-1569
8. Schindler RH, Chandler DB, Thresher R, Machemer R. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol ,1982;93;415-417
9. Ranson NT, Danis RP, Ciulla TA, Pratt L. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. Br J Ophthalmol ,2002;86:527-529
10. Damico FM. Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. The Retina Society. 37th Annual Scientific Meeting, Baltimore, Maryland, Sept.30-Oct.3,2004:126
11. Wang LL, Zhu ZQ, Wang Y, Wang HY. Effects of intravitreal administration of triamcinolone acetonide on postoperative proliferative vitreoretinopathy. Int J Ophthalmol (Guoji Yanke Zazhi) ,2005;5(4):685-687
12. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafitto CA, Reichel E, Baumal C. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology ,2002;109:920-927
13. Jonas JB, S'fker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.Am J Ophthalmol ,2001;132: 425-427
14. Kreissig I, Degenring RF, Jonas JB. Diffuses diabetisches Makulaoedem. Intraokularer Druck nach intravitrealem Triamcinolonacetonid. Ophthalmologe ,2005;102:153-157
15. Conway MD, Canakis C, Livir-Rallatos C, Peyman GA. Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg ,2003;29:27-33
16. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol ,2003;136: 384-386
17. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology ,2001;108:765-772
18. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol ,2002;86:247-248
19. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graef Arch Clin Exp Ophthalmol ,2002;240:782-783
20. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol ,1998; 26: 277-281
21. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina ,2000;20: 244-250
22. Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Aust NZ J Ophthalmol, 1995;23:293-298
23. Jonas JB, Kreissig I, Degenring RF. Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration. Brief Report. Graef Arch Clin Exp Ophthalmol ,2002;240: 872-873
24. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age-related macular degeneration. Br J Ophthalmol ,2003;87:462-468
25. Spandau UHM, Derse M, Schmitz-Valckenberg P, Sagstetter B-U, Stiefvater K, Jonas JR. Triamcinolone acetonide. Concentration after filtration of the solvent agent. Am J Ophthalmol ,2005;139:712-713